Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Plasma metabolites related to cellular energy metabolism are altered in adults with Down syndrome and Alzheimer's disease
Thomas Groß, Eric Doran, Amrita K. Cheema, et al.
Developmental Neurobiology (2019) Vol. 79, Iss. 7, pp. 622-638
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Blood-Based Biomarkers for Alzheimer’s Disease Diagnosis and Progression: An Overview
Angelica Varesi, Adelaide Carrara, Vitor Gomes Pires, et al.
Cells (2022) Vol. 11, Iss. 8, pp. 1367-1367
Open Access | Times Cited: 78
Down Syndrome Is a Metabolic Disease: Altered Insulin Signaling Mediates Peripheral and Brain Dysfunctions
Mara Dierssen, Marta Fructuoso, Maria Martínez de Lagrán, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 69
Meta-analysis of metabolites involved in bioenergetic pathways reveals a pseudohypoxic state in Down syndrome
László Pecze, Elisa B. Randi, Csaba Szabó
Molecular Medicine (2020) Vol. 26, Iss. 1
Open Access | Times Cited: 34
Blood Biomarkers for Alzheimer’s Disease in Down Syndrome
Laia Montoliu‐Gaya, André Strydom, Kaj Blennow, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 16, pp. 3639-3639
Open Access | Times Cited: 32
Mitochondrial Dysfunction in Down Syndrome: From Pathology to Therapy
Kai-Leng Tan, Han-Chung Lee, Pike-See Cheah, et al.
Neuroscience (2022) Vol. 511, pp. 1-12
Closed Access | Times Cited: 22
Switching diseased cells from cytosolic aerobic glycolysis to mitochondrial oxidative phosphorylation: A metabolic rhythm regulated by melatonin?
Russel J. Reıter, Ramaswamy Sharma, Qiang Ma
Journal of Pineal Research (2020) Vol. 70, Iss. 1
Closed Access | Times Cited: 32
The Clinical and Neuropathological Features of Sporadic (Late-Onset) and Genetic Forms of Alzheimer’s Disease
Tanzil Rujeedawa, Eva Carrillo Félez, I. C. H. Clare, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4582-4582
Open Access | Times Cited: 26
Down syndrome is an oxidative phosphorylation disorder
M. Pilar Bayona‐Bafaluy, Nuria Garrido-Pérez, Patricia Meade, et al.
Redox Biology (2021) Vol. 41, pp. 101871-101871
Open Access | Times Cited: 24
Dysregulated systemic metabolism in a Down syndrome mouse model
Dylan C. Sarver, Cheng Xu, Leandro M Velez, et al.
Molecular Metabolism (2022) Vol. 68, pp. 101666-101666
Open Access | Times Cited: 18
Role of cystathionine-β-synthase and hydrogen sulfide in down syndrome
Csaba Szabó
Neurotherapeutics (2025), pp. e00584-e00584
Open Access
Brain pyrimidine nucleotide synthesis and Alzheimer disease
Alba Pesini, Eldris Iglesias, M. Pilar Bayona‐Bafaluy, et al.
Aging (2019) Vol. 11, Iss. 19, pp. 8433-8462
Open Access | Times Cited: 29
Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization
QuanQiu Wang, Pamela B. Davis, Xin Qi, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 22
TransPhoM-DS Study Grant Report: Rationale and Protocol for Investigating the Efficacy of Low-Power Transcranial Photobiomodulation on Language, Executive Function, Attention, and Memory in Down Syndrome
Willians Fernando Vieira, David Richer Araujo Coelho, Maia B. Gersten, et al.
Photonics (2024) Vol. 11, Iss. 7, pp. 670-670
Open Access | Times Cited: 3
Metabolic correlates of prevalent mild cognitive impairment and Alzheimer's disease in adults with Down syndrome
Mark Mapstone, Thomas Groß, Fabìo Macciardi, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome
Alessandra Cadete Martini, Thomas Groß, Elizabeth Head, et al.
Neuron (2022) Vol. 110, Iss. 13, pp. 2063-2079
Open Access | Times Cited: 14
The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome
Ilaria Zuliani, Chiara Lanzillotta, Antonella Tramutola, et al.
Neurotherapeutics (2020) Vol. 18, Iss. 1, pp. 340-363
Open Access | Times Cited: 20
Distinct Basal Metabolism in Three Mouse Models of Neurodevelopmental Disorders
Caitlin Menzies, Shama Naz, David A. Patten, et al.
eNeuro (2021) Vol. 8, Iss. 2, pp. ENEURO.0292-20.2021
Open Access | Times Cited: 17
Trisomy 21 results in modest impacts on mitochondrial function and central carbon metabolism
Colin C. Anderson, John Marentette, Kendra M. Prutton, et al.
Free Radical Biology and Medicine (2021) Vol. 172, pp. 201-212
Open Access | Times Cited: 16
The functional roles of S‐adenosyl‐methionine and S‐adenosyl‐homocysteine and their involvement in trisomy 21
Maria Caracausi, Giuseppe Ramacieri, Francesca Catapano, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 709-724
Open Access | Times Cited: 2
Intestinal endogenous metabolites affect neuroinflammation in 5×FAD mice by mediating “gut-brain” axis and the intervention with Chinese Medicine
Xinru Gu, Miao-Xuan Fan, Yanyan Zhou, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The early diagnosis of Alzheimer's disease: Blood‐based panel biomarker discovery by proteomics and metabolomics
Yun Dong, Xun Song, Xiao Wang, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 11
Open Access | Times Cited: 2
Characterization of mitochondrial and metabolic alterations induced by trisomy 21 during neural differentiation
Kendra M. Prutton, John Marentette, Kenneth N. Maclean, et al.
Free Radical Biology and Medicine (2023) Vol. 196, pp. 11-21
Open Access | Times Cited: 6
Mechanistic Insights into Alzheimer’s Disease Unveiled through the Investigation of Disturbances in Central Metabolites and Metabolic Pathways
Raúl González‐Domínguez, Álvaro González‐Domínguez, Ana Sayago, et al.
Biomedicines (2021) Vol. 9, Iss. 3, pp. 298-298
Open Access | Times Cited: 11
Trisomy 21-driven metabolite alterations are linked to cellular injuries in Down syndrome
Juli Liu, Shaoxian Chen, Guiping Huang, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 1
Metabolic Shifts as the Hallmark of Most Common Diseases: The Quest for the Underlying Unity
Laurent Schwartz, Marc Henry, Khalid O. Alfarouk, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3972-3972
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top